Spago Nanomedical AB (SPAGO)

Currency in SEK
0.294
-0.001(-0.34%)
Closed·
SPAGO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 15 days
Fair Value
Day's Range
0.2850.294
52 wk Range
0.0920.460
Key Statistics
Prev. Close
0.295
Open
0.285
Day's Range
0.285-0.294
52 wk Range
0.092-0.46
Volume
69.32K
Average Volume (3m)
177.97K
1-Year Change
-17.13%
Book Value / Share
0.07
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SPAGO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Spago Nanomedical AB Company Profile

Spago Nanomedical AB (publ), a clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden. Its products include SpagoPix (SN132D), an MRI contrast agent, which is under Phase I development stage for the treatment of breast cancer, and under Phase II development stage for the treatment liver and pancreas cancer, as well as offers Tumorad (SN201), a radionuclide therapy for treatment of advanced and metastatic cancer, under preclinical development stage. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. The company was incorporated in 1999 and is based in Lund, Sweden.

Compare SPAGO to Peers and Sector

Metrics to compare
SPAGO
Peers
Sector
Relationship
P/E Ratio
−3.2x−15.9x−0.5x
PEG Ratio
−0.05−0.350.00
Price/Book
4.0x9.1x2.6x
Price / LTM Sales
15.2x69.2x3.3x
Upside (Analyst Target)
20.3%4.2%43.5%
Fair Value Upside
Unlock10.9%6.3%Unlock

Earnings

Latest Release
May 07, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
1.51M / --
EPS Revisions
Last 90 days

SPAGO Income Statement

FAQ

What Stock Exchange Does Spago Nanomedical AB Trade On?

Spago Nanomedical AB is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Spago Nanomedical AB?

The stock symbol for Spago Nanomedical AB is "SPAGO."

What Is the Spago Nanomedical AB Market Cap?

As of today, Spago Nanomedical AB market cap is 102.37M.

What Is Spago Nanomedical AB's Earnings Per Share (TTM)?

The Spago Nanomedical AB EPS (TTM) is -0.10.

When Is the Next Spago Nanomedical AB Earnings Date?

Spago Nanomedical AB will release its next earnings report on 19 Aug 2025.

From a Technical Analysis Perspective, Is SPAGO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Spago Nanomedical AB Stock Split?

Spago Nanomedical AB has split 4 times.

How Many Employees Does Spago Nanomedical AB Have?

Spago Nanomedical AB has 9 employees.

What is the current trading status of Spago Nanomedical AB (SPAGO)?

As of 05 Aug 2025, Spago Nanomedical AB (SPAGO) is trading at a price of 0.29, with a previous close of 0.30. The stock has fluctuated within a day range of 0.29 to 0.29, while its 52-week range spans from 0.09 to 0.46.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.